Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company is headquartered in Goleta, California and currently employs 753 full-time employees. The company went IPO on 2014-02-14. The company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. The company offers Simeox, which is an airway clearance device.
Mr. Kevin Smith 2023 'den beri şirketle birlikte olan Inogen Inc 'in President 'ıdır.
INGN hissesinin fiyat performansı nasıl?
INGN 'in mevcut fiyatı $6.31 'dir, son işlem günde 0% azalmış etti.
Inogen Inc için ana iş temaları veya sektörler nelerdir?
Inogen Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Inogen Inc 'in piyasa değerlemesi nedir?
Inogen Inc 'in mevcut piyasa değerlemesi $171.8M 'dir
Inogen Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 5 analist Inogen Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 5 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir